The Changing Role of Medication in Advancing Recovery NYAPRS Conference.

Slides:



Advertisements
Similar presentations
Treating Schizophrenia in Low And Middle Income (LAMI) Countries: Challenges and opportunities Treating Schizophrenia in Low And Middle Income (LAMI) Countries:
Advertisements

 Schizophrenia and other psychotic disorders Chapter 9.
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 35Seriously and Persistently Mentally Ill, Homeless, or Incarcerated Clients.
Poor Bipolar Outcome The Effect of Substance Abuse On Bipolar Disorder Phillip Long M.D.
Diagnosis and Management of Schizophrenia
UNIVERSITY OF JYVÄSKYLÄ OPEN DIALOGUE: Clients voices to be heard Jaakko Seikkula Seikkula, J. & Arnkil, TE (2006) Dialogical meetings in social networks.
OPEN DIALOGUE: Clients voices as resources Jaakko Seikkula Helsinki Seikkula, J. & Arnkil, TE: Open dialogues and anticipations. Respecting.
Managing Chronic Mental Illness in Primary Care  The “recovery” model of managing serious mental illness  Prognosis for Recovery  Tools and frameworks.
Increasing Services for persons with Schizophrenia Khadija Andrews 5 Minutes to Change Your Field CEP 532.
Jill Dennison Regional Lead, Western Region Schizophrenia Society of Ontario Mental illness and Seniors.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September-October 2007.
Treatment adherence: Factors, challenges, and solutions Paul R. Swaim; MEd, ALC MENTAL ILLNESS: CLOSING THE GAP BETWEEN NEEDS AND SERVICES -THE DISCONNECT.
Drug Therapy.  Although the causes of schizophrenia are still largely unknown, treatment for it focuses on lessening the type one and type two symptoms.
Evaluation of Drug Therapies in Treating Psychopathology.
PARANOID SCHIZOPHRENIA By: Kayla McCuen Anna Marsh.
Schizophrenia Case Study
Severe and Persistent Mental Illness and Mothers A Mothers’ Mental Health Toolkit Project Learning Video with Dr. Joanne MacDonald Reproductive Mental.
What is psychosis? D B Double
Managing Psychosis (NICE Guidelines 2014)
Infants and Young Children and Pandemic H1N1 Influenza Key learning from seasonal flu and previous pandemics Children less than 5 years of age have increased.
Mental disorder An introduction John Crichton Consultant Forensic Psychiatrist.
Open Dialogue: the future for EQUIP?
OPTIMAL TREATMENT INTERVENTIONS IN RECENT-ONCET PSYCHOSIS Vassilis P. Kontaxakis Associate Professor of Psychiatry, University of Athens.
PROFESSIONAL ACTIVITY AND SCHIZOPHRENIA: ASSOCIATED FACTORS AND IMPACT IN PROGNOSIS OUERFELLI I., JOMLI R., OUERTANI A., NACEF F. DEPARTMENT OF PSYCHIATRY.
Mental Health, Mental Illness and Chronic Disease Policy CMHA National Conference August 2008 Barbara Neuwelt, CMHA, Ontario.
Revision session 2: treatments for Schizophrenia 1 9 Briefly discuss two limitations of community care in the treatment of schizophrenia. (4 marks)
SERUM LEVELS OF IGF-1 IN FIRST EPISODE PSYCHOSIS AND CHRONIC SCHIZOPHRENIA PATIENTS COMPARED TO HEALTHY CONTROLS E. Ntouros 1, E. Karanikas 1, P. Ntafoulis.
Mental Health Services, University of Copenhagen 1.
Schizophrenia Terrence Gault.
LENGTH OF FIRST HOSPITALIZATION AND OTHER PREDICTORS FOR RE-HOSPITALIZATION IN PSYCHOSES Jouko Miettunen, PhD Department of Psychiatry University of Oulu,
Economic evaluation of psychotherapy for personality disorders: burden of disease and cost-effectiveness Djøra Soeteman Viersprong Institute for Studies.
Shaul Lev-Ran, MD Shalvata Mental Health Center
The Swedish National Forensic Psychiatric Register Margareta Lagerkvist Senior Psychiatrist Sweden.
Mental Disorders & Resources for Help 7.MEH.3.1. Jacob Jacob is part of the local all-star baseball team. He just finished a long practice and decided.
By: Jessica Williams.  Schizophrenia is a chronic, severe and disabling brain disorder.  Schizophrenia usually begins in early adulthood around the.
Going back to work or to study after a first-episode psychosis : the impact of an early intervention program over 5 years Amal Abdel-Baki (1,2), Geneviève.
3 Revolutions in Psychology - Psychiatry Psychotherapeutic Drugs.
Updated by Gary Bond Evidence for the Effectiveness of Individual Placement and Support Model of Supported Employment.
Schizophrenia Rebecca Love.
Schizoaffective Disorder in Life
The first year of Community Treatment Orders Dr M Claire Royston MB ChB MSc FRCPsych Medical Director Care Principles Lead SOAD, Care Quality Commission.
Section 4.4 Treating Mental Disorders Slide 1 of 14 Objectives List reasons that might prevent a person from seeking help for a mental disorder. Identify.
Whole person care. Growth of specialist services Coexisting conditions Focus of secondary care, benefits of community care providers How are we doing?
1 International Society for CNS Clinical Trials and Methodology FDA Advisory Committee Meeting Proposed Requirement for Long-Term Data to Support Initial.
Clinical Epidemiology and Evidence-based Medicine Unit FKUI – RSCM
7th Grade 7.MEH.3.1. Objective 3.1  Identify resources that would be appropriate for treating common mental disorders.
3 Revolutions in Psychology - Psychiatry Psychotherapeutic Drugs.
By: DJ Kyles.  Bipolar disorder (also known as manic depression) causes serious shifts in mood, energy, thinking, and behavior– from the highs of mania.
Susan Gingerich, MSW A Brief Overview of First Episode Psychosis and A Description of the NAVIGATE Program Susan Gingerich, MSW
PSYCHOTHERAPIES FOR BIPOLAR DISORDER Keith R Laws University of Hertfordshire
Medication for Psychosis: Myths and Truths Demian Rose, MD, PhD UCSF Assistant Professor PREP Medical Director PREP Prevention and Recovery of Early Psychosis.
Integrated Care for Veterans with Diabetes & Serious Mental Illness Judith A. Long, MD Steven C. Marcus, PhD.
Psychosis: Course & Prognosis NORTH WEST SCHOOL OF PSYCHIATRY MRCPSYCH COURSE SLIDES BY DR S WHEELER.
Bipolar Disorder. What is it? Definition: “previously known as manic depression - is a condition that affects your moods, which can swing from one extreme.
Myth: Depression results from a personality weakness or character flaw, and people who are depressed could just snap out of it if they tried hard enough.
PSYCHOTIC DISORDER Mental Health First Aid By Mental Health Commission of Canada, 2010.
Date of download: 9/20/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of a Palliative Care Intervention on Clinical.
Research methods- Clinical
Mental Health TS Conference 2017
Expansion of Early Psychosis Care in U.S. Community Settings
OF PHARMACOLOGICAL TREATMENT IN PATIENTS WITH SEVERE MENTAL ILLNESS
Module 19 Mental Health Revised.
Schizophrenia Drug therapy – typical and atypical antipsychotics
Introduction. Clinical Scenario: Encouraging Adherence in Patients with Schizophrenia.
The Changing Role of Medication
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
The Challenges of Bipolar Disorders
OPEN DIALOGUE: Naturalistic study designs for developing the system to reduced medication Jaakko Seikkula
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Presentation transcript:

The Changing Role of Medication in Advancing Recovery NYAPRS Conference

Martin Harrow’s Long-Term Study of Psychotic Patients Patient Enrollment  64 schizophrenia patients  81 patients with other psychotic disorders 37 psychotic bipolar patients 28 unipolar psychotic patients 16 other milder psychotic disorders  Median age of 22.9 years at index hospitalization  Previous hospitalization 46% first hospitalization 21% one previous hospitalization 33% two or more previous hospitalizations Source: Harrow M. “Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications.” Journal of Nervous and Mental Disease 195 (2007):

Long-term Recovery Rates for Schizophrenia Patients 50% 40% 30% 20% Off Antipsychotics 10% On Antipsychotics 0% 2 years 4.5 years 7.5 years 10 years 15 years Source: Harrow M. “Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications.” Journal of Nervous and Mental Disease 195 (2007):

Global Adjustment of Schizophrenia Patients Worst outcomes Best outcomes On Antipsychotics Off Antipsychotics 2 years 4.5 years 7.5 years 10 years 15 years Source: Harrow M. “Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications.” Journal of Nervous and Mental Disease 195 (2007):

Spectrum of Outcomes in Harrow’s Study Recovered FairUniformly Poor On Antipsychotics Off Antipsychotics %25%50%75%100% Source: Harrow M. “Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications.” Journal of Nervous and Mental Disease 195 (2007):

Schizophrenia Patients Experiencing Psychotic Symptoms Over the Long Term O ff antipsychotics On Antipsychotics 100% 10-year followup 15-year followup Source: Harrow M. “Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications.” Journal of Nervous and Mental Disease 195 (2007): % 50% 25% 0%

Global Adjustment of “Other Psychotic” Patients Worst outcomes On Antipsychotics Off Antipsychotics 1 Best outcomes 0 2 years 4.5 years 7.5 years 10 years 15 years Source: Harrow M. “Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications.” Journal of Nervous and Mental Disease 195 (2007):

Global Adjustment of All Psychotic Patients Worst outcomes Schizophrenia On Meds Other Disorders On Meds Schizophrenia Off Meds Other Disorders Off Meds Best outcomes 2 years 4.5 years 7.5 years 10 years 15 years Source: Harrow M. “Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications.” Journal of Nervous and Mental Disease 195 (2007):

“In addition, global outcome for the group of patients with schizophrenia who were on antipsychotics was compared with the off- medication schizophrenia patients with similar prognostic status. Starting with the 4.5-year follow-up and extending to the 15- year follow-up, the off-medication subgroup tended to show better global outcomes at each followup.” Martin Harrow, page 411.

Five-Year Outcomes for First-Episode Psychotic Patients in Finnish Western Lapland Treated with Open-Dialogue Therapy Patients (N=75) Schizophrenia (N=30) Other psychotic disorders (N=45) Antipsychotic use Never exposed to antipsychotics Occasional use during fi ve years Ongoing use at end of fi ve years 67% 33% 20% Psychotic symptoms Never relapsed during fi ve years Asymptomatic at fi ve-year followup 67% 79% Functional outcomes at fi ve years Working or in school Unemployed On disability 73% 7% 20% Source: Seikkula, J. “Five-year experience of fi rst-episode nona ff ective psychosis in open-dialogue approach.” Psychotherapy Research 16 (2006):